These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 26567239)

  • 1. Effect of oral naloxone on opioid-induced constipation in methadone maintenance treatment patients, a double-blind, placebo-control, clinical trial.
    Akhgarandouz S; Moshiri M; Etemad L; Dadpour B; Khadem-Rezaiyan M; Vahdati-Mashhadian N
    Ir J Med Sci; 2024 Mar; ():. PubMed ID: 38502432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis.
    Chopra MP; Feldman Z; Mancino MJ; Oliveto A
    Pharmacol Biochem Behav; 2008 Oct; 90(4):787-96. PubMed ID: 18585405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killing the symptom without killing the patient.
    Gallagher R
    Can Fam Physician; 2010 Jun; 56(6):544-6, e210-12. PubMed ID: 20547520
    [No Abstract]   [Full Text] [Related]  

  • 4. We Need to Talk About Methadone: Adding Discussions With Patients to Our Care Pathways.
    Stone AB; Gerner P; Bader AM; Soffin EM
    Anesth Analg; 2024 Jan; 138(1):e3-e4. PubMed ID: 38100811
    [No Abstract]   [Full Text] [Related]  

  • 5. Opioid-induced constipation reversal in response to placebo in a patient with a history of IBS receiving methadone maintenance therapy.
    Samokhvalov AV; Rehm J
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26567239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.
    Sanders M; Jones S; Löwenstein O; Jansen JP; Miles H; Simpson K
    Pain Med; 2015 Aug; 16(8):1540-50. PubMed ID: 26110375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a fixed-dose opioid agonist/antagonist on constipation in patients on long-term opioids for non-malignant pain unable to tolerate laxatives.
    Mehta V; Alaward S; Kuravinakop S; Nikolic S
    Pain Physician; 2014; 17(5):415-24. PubMed ID: 25247899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.
    Sykes NP
    Palliat Med; 1996 Apr; 10(2):135-44. PubMed ID: 8800821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone.
    Morlion B; Clemens KE; Dunlop W
    Clin Drug Investig; 2015 Jan; 35(1):1-11. PubMed ID: 25479959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients.
    Ueberall MA; Müller-Lissner S; Buschmann-Kramm C; Bosse B
    J Int Med Res; 2011; 39(1):41-50. PubMed ID: 21672306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation.
    Rentz AM; Yu R; Müller-Lissner S; Leyendecker P
    J Med Econ; 2009; 12(4):371-83. PubMed ID: 19912069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio.
    Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA
    Exp Clin Psychopharmacol; 2009 Jun; 17(3):146-53. PubMed ID: 19586229
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.